$ANRO· SEC filing ·

ANRO Acquires ALTO-207 for TRD, $50M PIPE, $177M Cash to 2028, Phase 2b 2026, Lancet d=0.87

Alto Neuroscience Inc. · PHARMACEUTICAL PREPARATIONS · Now $19.80

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS